We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor. Intercept Pharmaceuticals is a biotech company focused on developing and commercializing novel therapeutics to treat chronic liver diseases. Obeticholic acid, or OCA, is an agonist of the farnesoid X receptor.
sNDA intended to satisfy post-marketing requirements to confirm a clinical benefit in patients with PBCPrecedent-setting submission includes data from post-marketing studies COBALT and Study 401...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0.24 | 1.27931769723 | 18.76 | 19.02 | 18.76 | 1829307 | 18.95922128 | CS |
52 | 0.01 | 0.0526592943655 | 18.99 | 19.37 | 8.8216 | 1681876 | 14.91306541 | CS |
156 | -2.25 | -10.5882352941 | 21.25 | 22.36 | 8.8216 | 1049490 | 15.85991834 | CS |
260 | -71.93 | -79.1048058946 | 90.93 | 125 | 8.8216 | 927719 | 30.84295432 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions